(R)-Posenacaftor sodium

Modify Date: 2024-01-16 18:27:47

(R)-Posenacaftor sodium Structure
(R)-Posenacaftor sodium structure
Common Name (R)-Posenacaftor sodium
CAS Number 2095064-09-6 Molecular Weight 467.49
Density N/A Boiling Point N/A
Molecular Formula C27H26NNaO5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (R)-Posenacaftor sodium


(R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor. Posenacaftor is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of CFTR protein. Posenacaftor is used for the research of cystic fibrosis (CF)[1].

 Names

Name (R)-Posenacaftor sodium

 (R)-Posenacaftor sodium Biological Activity

Description (R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor. Posenacaftor is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of CFTR protein. Posenacaftor is used for the research of cystic fibrosis (CF)[1].
Related Catalog
Target

IC50: CFTR[1]

In Vitro Cystic fibrosis (CF) is an autosomal recessive disorder, caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR)[1]. CFTR is a cAMP-regulated chloride channel that is primarily located at the apical membrane of epithelial cells. Mutations in the CFTR gene lead to the production of a defective and misfolded CFTR protein, and impairs the flow of ions in and out of cells[1]. Posenacaftor is a CFTR corrector, correctors are designed to fix and restore the function of the defective CFTR protein. The corrected CFTR then moves to the cell surface, where it functions as a chloride channel and helps maintain the right balance of fluid in the airways[2].
References

[1]. Benjamin Kopp, et al. Compositions et procédés pour améliorer la fonction cftr dans des cellules affectées par la fibrose kystique. Patent WO2019156946.

 Chemical & Physical Properties

Molecular Formula C27H26NNaO5
Molecular Weight 467.49